22nd Century Group (Nasdaq: XXII) Supports Federal Proposal to Require Less Nicotine in All U.S. Cigarettes
June 22, 2022
Ryan Allway June 22nd, 2022 News, Top News FDA’s Proposed Rule Draws on Research That Supports Reduced Nicotine Content Cigarettes Are Less Addictive 22nd Century Group’s FDA MRTP Authorized 95% Reduced Nicotine Cigarette Products Is Already Available to Meet Proposed Policy to Reduce Nicotine in All Cigarettes VLN® Pilot Sales... Read more
Ryan Allway June 16th, 2022 News, Top News CFO of GVB Biopharma to Expand Role, Become CFO of 22nd Century Group Integration of GVB Biopharma Proceeding at a Rapid Pace BUFFALO, N.Y., June 16, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company), dedicated to... Read more
